New baculovirus recombinants expressing Pseudorabies virus (PRV) glycoproteins protect mice against lethal challenge infection

Vaccine

Volumn 27, Issue 27, 2009, Pages 3584-3591

  Grabowska, Agnieszka K ^a,b   Lipińska, Andrea D ^a   Rohde, Jörg ^b   Szewczyk, Boguslaw ^a   Bienkowska Szewczyk, Krystyna ^a   Rziha, Hanns Joachim ^b  

^a UNIVERSITY OF GDA SK   (Poland)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

Baculovirus recombinant; Protective immunization; Pseudorabies virus; Viral vector vaccine; VSV G protein

Indexed keywords

ALPHA INTERFERON; BACULOVIRUS VECTOR; GAMMA INTERFERON; IMMUNOGLOBULIN G2A; PSEUDORABIES VACCINE; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; IMMUNOGENICITY; INTERFERON PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; PSEUDORABIES; VACCINATION; VACCINE PRODUCTION; VESICULAR STOMATITIS VIRUS; VIRUS RECOMBINANT; VIRUS RESISTANCE;

ANIMALS; ANTIBODIES, VIRAL; BACULOVIRIDAE; HERPESVIRUS 1, SUID; INTERFERON-GAMMA; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 67349137103     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.03.067     Document Type: Article

References (64)

1. Marshall E. Gene therapy death prompts review of adenovirus vector. Science 286 (1999) 2244-2245
2. Brave A., Ljungberg K., Wahren B., and Liu M.A. Vaccine delivery methods using viral vectors. Mol Pharm 4 (2007) 18-32
3. Thomas C.E., Ehrhardt A., and Kay M.A. Progress and problems with the use of viral vectors for gene therapy. Nature Rev Genet 4 (2003) 346-358
4. Shams H. Recent developments in veterinary vaccinology. Vet J 170 (2005) 289-299
5. Paoletti E. Applications of pox virus vectors to vaccination: an update. Proc Natl Acad Sci USA 93 (1996) 11349-11353
6. Patterson R.M., Selkirk J.K., and Merrick B.A. Baculovirus and insect cell gene expression-review of baculovirus biotechnology. Environ Health Perspect 103 (1995) 756-759
7. Beljelarskaya S.N. A baculovirus expression system for insect cells. Mol Biol 36 (2002) 281-292
8. Boyce F.M., and Buchner N.L.R. Baculovirus-mediated gene transfer into mammalian cells. Proc Natl Acad Sci USA 93 (1996) 2348-2352
9. Dudek T., and Knipe D.M. Replication-defective viruses as vaccines and vaccine vectors. Virology 344 (2006) 230-239
10. Smith C.L., Mirza F., Pasquetto V., Tscharke D.C., Palmowski M.J., Dunbar P.R., et al. Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara. J Immunol 175 (2005) 8431-8437
11. Gromadzka B., Szewczyk B., Konopa G., Mitzner A., and Kesy A. Recombinant VP60 in the form of virion-like particles as a potential vaccine against rabbit hemorrhagic disease virus. Acta Biochim Pol 53 (2006) 371-376
12. Matassov P., Cupo A., and Galarza J.M. A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1). Viral Immunol 20 3 (2007) 441-452
13. Hofmann C., Sanding V., Jennings G., Rudolph M., Schlag P., and Strauss M. Efficient gene-transfer into human hepatocytes by baculovirus vectors. Proc Natl Acad Sci USA 92 (1995) 10099-10103
14. Sarkis C., Serguera C., Peters S., Buichet D., Rider J.L., Edelman L., et al. Efficient transduction of neural cells in vitro and in vivo by a baculovirus-derived vector. Proc Natl Acad Sci USA 97 (2000) 14638-14643
15. Pieroni L., Maione D., and La Monica N. In vivo gene transfer in mouse skeletal muscle mediated by baculovirus vectors. Hum Gene Ther 12 (2001) 871-881
16. Ho Y.C., Chen H.C., Wang K.C., and Hu Y.C. Highly efficient baculovirus-mediated gene transfer into rat chondrocytes. Biotechnol Bioeng 88 (2004) 643-651
17. Barsoum J., Brown R., McKee M., and Boyce F.M. Efficient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein. Hum Gene Ther 8 (1997) 2011-2018
18. Shoji I., Aizaki H., Tani H., Ishii K., Chiba T., Saito I., et al. Efficient gene transfer into various mammalian cells, including non-hepatic cells, by baculovirus vectors. J Gen Virol 78 (1997) 2657-2664
19. Aoki H., Sakoda Y., Jukuroki K., Takada A., Kida H., and Fukusho A. Induction of antibodies in mice by a recombinant baculovirus expressing pseudorabies virus glycoprotein B in mammalian cells. Vet Microbiol 68 (1999) 197-207
20. Abe T., Takahashi H., Hamazaki H., Miyano-Kurosaki N., Matsuura Y., and Takaku H. Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. J Immunol 171 (2003) 1133-1139
21. Facciabene A., Aurisicchio L., and La Monica N. Baculovirus vectors elicit antigen-specific immune responses in mice. J Virol 78 (2004) 8663-8672
22. Kimman T.G., Gielkens A.J.L., Glazenburg K., Jacobs L., De Jong M.C.M., Mulder W.A.M., et al. Characterization of live pesudorabies virus vaccines. Dev Biol Stand 84 (1995) 89-96
23. Wittmann G., and Rziha H.J. Aujeszky's disease (pseudorabies) in pigs. Herpesvirus diseases of cattle, horses and pigs (1989), Kulwer Academic, Boston, MA p. 230-325
24. Van Oirschot J.T. Intranasal vaccination of pigs against Aujeszky's disease: comparison with one or two doses of attenuated vaccines in pigs with high maternal antibody titers. Res Vet Sci 42 (1987) 12-16
25. Visser N., and Rziha H.J. Is recombination of PRV vaccine strains a real problem?. Acta Vet Hung 42 (1994) 183-193
26. Stegeman A., de Jong M.C., van Nes A., and Bouma A. Dynamics of pseudorabies virus infections in vaccinated pig populations: a review. Vet Q 19 (1997) 117-122
27. Mettenleiter T.C. Immunobiology of pseudorabies (Aujeszky's disease). Vet Immunol Immunopathol 54 (1996) 221-229
28. Zuckermann F.A., Zsak L., Mettenleiter T.C., and Ben-Porat T. Pseudorabies virus glycoprotein gIII is a major target antigen for murine and swine virus-specific cytotoxic T lymphocytes. J Virol 64 (1990) 802-812
29. Eloit M., Fargeaund D., L'Haridon R., and Toma B. Identification of the pseudorabies glycoprotein gp50 as a major target of neutralizing antibodies. Arch Virol 99 (1988) 45-56
30. Ben-Porat T., DeMarchi J., Lomniczi B., and Kaplan A.S. Role of glycoproteins of pseudorabies virus in eliciting neutralizing antibodies. Virology 154 (1986) 325-334
31. Kimman T.G., De Bruin T.G.M., Voermans J.J.M., Peeters B.P.H., and Bianchi A.T.J. Development and antigen specificity of the lymphoproliferation response of pigs to pseudorabies virus: dichotomy between secondary B- and T-cell responses. Immunology 86 (1996) 372-378
32. Mukamoto M., Watanabe I., Kobayashi Y., Icatlo Jr. F.C., Ishii H., and Kodama Y. Immunogenicity in Aujeszky's disease virus structural glycoprotein gVI (gp50) in swine. Vet Microbiol 29 (1991) 109-121
33. Fischer T., Planz O., Stitz L., and Rziha H.J. Novel recombinant parapoxvirus vectors induce protective humoral and cellular immunity against lethal herpesvirus challenge infection in mice. J Virol 77 (2003) 9312-9323
34. Dory D., Fischer T., Beven V., Cariolet R., Rziha H.J., and Jestin A. Prime-boost immunization using DNA vaccine and recombinant Orf virus protects pigs against Pseudorabies virus (herpes suid 1). Vaccine 24 (2006) 6256-6263
35. Hsu C.S., Ho Y.C., Wang K.C., and Hu Y.C. Investigation of optimal transduction conditions for baculovirus-mediated gene delivery into mammalian cells. Biotechnol Bioeng 88 (2004) 42-51
36. Planz O., and Stitz L. Borna disease virus nucleoprotein (p40) is a major target for CD8(+)-T-cell-mediated immune response. J Virol 73 (1999) 1715-1718
37. Gerdts V., Joens A., and Mettenleiter T.C. Potency of an experimental DNA vaccine against Aujeszky's disease in pigs. Vet Microbiol 66 (1999) 1-13
38. Kost T.A., Condreay J.P., and Jarvis D.L. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 23 (2005) 567-575
39. Hu Y.C. Baculovirus as a highly efficient expression vector in insect and mammalian cells. Acta Pharmacol Sin 26 (2005) 405-416
40. van Rooij E.M.A., de Bruin M.G.M., de Visser Y.E., Middel W.G.J., Boersma W.J.A., and Bianchi A.T.J. Vaccine-induced T cell-mediated immunity plays a critical role in early protection against pseudorabies virus (suid herpes virus type 1) infection in pigs. Vet Immunol Immunopathol 99 (2004) 113-125
41. + cells in protective immunity. Vaccine 16 (1998) 1550-1558
42. Hu Y.C., Yao K., and Wu T.Y. Baculovirus as an expression and/or delivery vehicle for vaccine antigens. Expert Rev Vaccines 7 (2008) 363-371
43. Gronowski A.M., Hilbert D.M., Sheehan K.C.F., Garotta G., and Schreiber R.D. Baculovirus stimulates antiviral effects in mammalian cells. J Virol 73 (1999) 9944-9951
44. Cunningham A.L., Diefenbach R.J., Miranda-Saksena M., Bosnjak L., Kim M., Jones C., et al. The cycle of human herpes simplex virus infection: virus transport and immune control. J Infect Dis 15 194 Suppl. 1 (2006) S11-S18
45. Onodera T., Yoshihara K., Suzuki T., Tsuda T., Ikeda T., Awaya A., et al. Resistance to pseudorabies virus with enhanced interferon production and natural killer cell activity in mice treated with serum thymic factor. Microbiol Immunol 38 (1994) 47-53
46. Tudor D., Riffault S., Carrat C., Lefèvre F., Bernoin M., and Charley B. Type I IFN modulates the immune response induced by DNA vaccination to pseudorabies virus glycoprotein C. Virology 20 (2001) 197-205
47. Vivier E., Tomasello E., Baratin M., Walzer T., and Ugolini S. Functions of natural killer cells. Nat Immunol 9 (2008) 503-510
48. Pulendran B., and Ahmed R. Translating innate immunity into immunological memory: implications for vaccine development. Cell 24 124 (2006) 849-863
49. Guy B. The perfect mix: recent progress in adjuvant research. Nat Rev Microbiol 5 (2007) 505-517
50. Kawai T., and Akira S. Innate immune recognition of viral infection. Nat Immunol 7 (2006) 131-137
51. Martín-Fontecha A., Thomsen L.L., Brett S., Gerard C., Lipp M., Lanzavecchia A., et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 5 (2004) 1260-1265
52. Yoon H.A., Aleyas A.G., George J.A., Park S.O., Han Y.W., Kang S.H., et al. Differential segregation of protective immunity by encoded antigen in DNA vaccine against pseudorabies virus. Immunol Cell Biol 84 (2006) 502-511
53. Schijns V.E., Haagmans B.L., Rijke E.O., Huang S., Aguet M., and Horzinek M.C. IFN-gamma receptor-deficient mice generate antiviral Th1-characteristic cytokine profiles but altered antibody responses. J Immunol 153 (1994) 2029-2037
54. Fischer T., Büttner M., and Rziha H.J. T helper 1-type cytokine transcription in peripheral blood mononuclear cells of pseudorabies virus (Suid herpesvirus 1)-primed swine indicates efficient immunization. Immunology 101 (2000) 378-387
55. Hoegen B., Saalmüller A., Röttgen M., Rziha H.J., Geldermann H., Reiner G., et al. Interferon-gamma response of PBMC indicates productive pseudorabies virus (PRV) infection in swine. Vet Immunol Immunopathol 102 (2004) 389-397
56. van Rooij E.M., Haagmans B.L., de Visser Y.E., de Bruin M.G., Boersma W., and Bianchi A.T. Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigs. Vet Immunol Immunopathol 66 (1998) 113-126
57. Ober B.T., Summerfield A., Mattlinger C., Wiesmüller K.H., Jung G., Pfaff E., et al. Vaccine-induced, pseudorabies virus-specific, extrathymic CD4+ CD8+ memory T-helper cells in swine. J Virol 72 (1998) 4866-4873
58. Ober B.T., Teufel B., Wiesmüller K.H., Jung G., Pfaff E., Saalmüller A., et al. The porcine humoral immune response against pseudorabies virus specifically targets attachment sites on glycoprotein gC. J Virol 74 (2000) 1752-1760
59. Mengeling W.L., Brockmeier S.L., and Lager K.M. Evaluation of a recombinant vaccinia virus containing pseudorabies (PR) virus glycoprotein genes gp50, gII, and gIII as a PR vaccine for pigs. Arch Virol 134 (1994) 259-269
60. Riviere M., Tartaglia J., Perkus M.E., Norton E.K., Bongermino C.M., Lacoste F., et al. Protection of mice and swine from pseudorabies virus conferred by vaccinia virus-based recombinants. J Virol 66 (1992) 3424-3434
61. Xiao S., Chen H., Fang L., Liu C., Zhang H., Jiang Y., et al. Comparison of immune responses and protective efficacy of suicidal DNA vaccine and conventional DNA vaccine encoding glycoprotein C of Pseudorabies virus in mice. Vaccine 22 (2004) 345-351
62. Gerdts V., Jöns A., Makoschey B., visser N., and Mettenleiter T.C. Protection of pigs against Aujeszky's disease by DNA vaccination. J Gen Virol 78 (1997) 2139-2146
63. Bachmann M.F., Kalinke U., Althage A., Freer G., Burkhart C., Roost H.-P., et al. Science 276 (1997) 2024-2027
64. Strauss R., Hüser A., Ni S., Tuve S., Kiviat N., Sow P.S., et al. Baculovirus-based vaccination vectors allow for efficient induction of immune responses against Plasmodium falciparum circumsporozoite protein. Mol Ther 15 (2007) 193-202